PAPER Annaert W, De Strooper B
SEARCH RESULTS
329930 RESULTS
PAPER Blond B
[4/5 Alzheimer's disease].
Soins. 2010 May;(745):51-2. PubMed: 20509497PAPER Kataoka K, Hashimoto H, Kawabe J, Higashiyama S, Akiyama H, Shimada A, Kai T, Inoue K, Shiomi S, Kiriike N
Frontal hypoperfusion in depressed patients with dementia of Alzheimer type demonstrated on 3DSRT.
Psychiatry Clin Neurosci. 2010 Jun;64(3):293-8. PubMed: 20602729PAPER Skura E
Global standards for Alzheimer research under development.
CMAJ. 2010 Aug 10;182(11):E509-10. PubMed: 20603352PAPER Wilson RS, Hoganson GM, Rajan KB, Barnes LL, Mendes de Leon CF, Evans DA
Temporal course of depressive symptoms during the development of Alzheimer disease.
Neurology. 2010 Jul 6;75(1):21-6. PubMed: 20603481PAPER Dotson VM, Beydoun MA, Zonderman AB
Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment.
Neurology. 2010 Jul 6;75(1):27-34. PubMed: 20603482PAPER Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R
Depressive symptoms and risk of dementia: the Framingham Heart Study.
Neurology. 2010 Jul 6;75(1):35-41. PubMed: 20603483PAPER Roe CM, Mintun MA, Ghoshal N, Williams MM, Grant EA, Marcus DS, Morris JC
Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept.
Neurology. 2010 Jul 6;75(1):42-8. PubMed: 20603484PAPER Saleh N, Moutereau S, Azulay JP, Verny C, Simonin C, Tranchant C, El Hawajri N, Bachoud-Lévi AC, Maison P,
High insulinlike growth factor I is associated with cognitive decline in Huntington disease.
Neurology. 2010 Jul 6;75(1):57-63. PubMed: 20603485PAPER Charras K, Frémontier M
Sharing meals with institutionalized people with dementia: a natural experiment.
J Gerontol Soc Work. 2010;53(5):436-48. PubMed: 20603753PAPER Pieper AA, Xie S, Capota E, Estill SJ, Zhong J, Long JM, Becker GL, Huntington P, Goldman SE, Shen CH, Capota M, Britt JK, Kotti T, Ure K, Brat DJ, Williams NS, MacMillan KS, Naidoo J, Melito L, Hsieh J, De Brabander J, Ready JM, McKnight SL
Discovery of a proneurogenic, neuroprotective chemical.
Cell. 2010 Jul 9;142(1):39-51. PubMed: 20603013PAPER Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y, Wahlund LO, Westman E, Kinsey A, Güntert A, Proitsi P, Powell J, Causevic M, Killick R, Lunnon K, Lynham S, Broadstock M, Choudhry F, Howlett DR, Williams RJ, Sharp SI, Mitchelmore C, Tunnard C, Leung R, Foy C, O'Brien D, Breen G, Furney SJ, Ward M, Kloszewska I, Mecocci P, Soininen H, Tsolaki M, Vellas B, Hodges A, Murphy DG, Parkins S, Richardson JC, Resnick SM, Ferrucci L, Wong DF, Zhou Y, Muehlboeck S, Evans A, Francis PT, Spenger C, Lovestone S
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease.
Arch Gen Psychiatry. 2010 Jul;67(7):739-48. PubMed: 20603455PAPER Chwiej J
The use of cluster and discriminant analysis in the investigations of the role of trace metals in the pathogenesis of Parkinson's disease.
J Trace Elem Med Biol. 2010 Apr;24(2):78-88. PubMed: 20413064APP binding family B, 1
ANTIBODY polyclonal manufacturer Cat# EBT-EB07373 <br />supplied by Everest Biotec immunogen = peptide with sequence C-G S L K P K R L G A H T P, from the C- terminus of the protein seq. according to NP_001155.1; NP_663722.1 liquid, TBS, BSA, azide, affinity
APPβ
ANTIBODY polyclonal manufacturer Cat# CO-SIG-39138 <br />supplied by Covance liquid, PBS, no preservative, affinity purified recognizes the soluble fragment of the β-secretase cleaved N-terminus of human amyloid precursor protein (APP). Weak cross-reaction w
Current Filters
No filters selected